[1] Li Z, Ding Z, Rong D, et al. Overexpression of lncRNA AFAP1-AS1 promotes cell proliferation and invasion in gastric cancer[J]. Oncol Lett, 2019, 18(3): 3211-3217. [2] Huang M, Hou J, Wang Y, et al. Long noncoding RNA LINC00673 is activated by SP1 and exerts oncogenic properties by interacting with LSD1 and EZH2 in gastric cancer[J]. Mol Ther, 2017, 25(4): 1014-1026. [3] Childs EJ, Mocci E, Campa D, et al. Common variation at 2p13.3, 3q29, 7p13 and 17q25.1 associated with susceptibility to pancreatic cancer[J]. Nat Genet, 2015, 47(8): 911-916. [4] Zhang B, Li C, Sun Z. Long non-coding RNA LINC00346, LINC00578, LINC00673, LINC00671, LINC00261, and SNHG9 are novel prognostic markers for pancreatic cancer[J]. Am J Transl Res, 2018, 10(8): 2648-2658. [5] Lu W, Zhang H, Niu Y, et al. Long non-coding RNA linc00673 regulated non-small cell lung cancer proliferation, migration, invasion and epithelial mesenchymal transition by sponging miR-150-5p[J]. Mol Cancer, 2017, 16(1): 118. [6] Abdul-Rahman U, Györffy B, Adams BD. linc00673 (ERRLR01) is a prognostic indicator of overall survival in breast cancer[J]. Transcription, 2018, 9(1): 17-29. [7] Ba MC, Long H, Cui SZ, et al. Long noncoding RNA LINC00673 epigenetically suppresses KLF4 by interacting with EZH2 and DNMT1 in gastric cancer[J]. Oncotarget, 2017, 8(56): 95542-95553. [8] 范有寿, 邱志胜, 赵亚萍. 硫氧还蛋白还原酶1(TrxR1)在胃癌中的表达及对胃癌细胞生长的影响[J]. 中国应用生理学杂志, 2020, 36(4): 324-329. [9] 赵翔宇, 何振宇, 宰守峰. 人参皂苷Rg5对胃癌细胞周期和侵袭的影响及其机制[J]. 中国应用生理学杂志, 2020, 36(1): 51-55. [10] Zheng J, Huang X, Tan W, et al. Pancreatic cancer risk variant in LINC00673 creates a miR-1231 binding site and interferes with PTPN11 degradation[J]. Nat Genet, 2016, 48(7): 747-957. [11] Ma C, Wu G, Zhu Q, et al. Long intergenic noncoding RNA 00673 promotes non-small-cell lung cancer metastasis by binding with EZH2 and causing epigenetic silencing of HOXA5[J]. Oncotarget, 2017, 8(20): 32696-32705. [12] Zhang LG, Zhou XK, Zhou RJ, et al. Long non-coding RNA LINC00673 promotes hepatocellular carcinoma progression and metastasis through negatively regulating miR-205[J]. Am J Cancer Res, 2017, 7(12): 2536-2544. [13] Xia E, Bhandari A, Shen Y, et al. lncRNA LINC00673 induces proliferation, metastasis and epithelial-mesenchymal transition in thyroid carcinoma via Kruppel-like factor 2[J]. Int J Oncol, 2018, 53(5): 1927-1938. [14] Xia E, Shen Y, Bhandari A, et al. Long non-coding RNA LINC00673 promotes breast cancer proliferation and metastasis through regulating B7-H6 and epithelial-mesenchymal transition[J]. Am J Cancer Res, 2018, 8(7): 1273-1287. [15] Gao S, Zhao Z, Wu R, et al. Prognostic value of long noncoding RNAs in gastric cancer: a meta-analysis. Onco Targets and Therapy[J]. Onco Targets Ther, 2018, 11: 4877-4891. [16] Cen D, Huang H, Yang L, et al. Long noncoding RNA STXBP5-AS1 inhibits cell proliferation, migration, and invasion through inhibiting the PI3K/AKT signaling pathway in gastric cancer cells[J]. Onco Targets Ther, 2019, 12: 1929-1936. [17] Zhang F, Huang Y, Wang B, et al. LINC00673 silencing inhibits cell migration and invasion by suppressing PI3K/AKT signaling in glioma[J]. Neuroreport, 2018, 29(9): 718-722. [18] Hsu W, Liu L, Chen X, Zhang Y, et al. LncRNA CASC11 promotes the cervical cancer progression by activating Wnt/beta-catenin signaling pathway[J]. Biol Res, 2019, 52(1): 33. [19] Guan H, Zhu T, Wu S, et al. Long noncoding RNA LINC00673-v4 promotes aggressiveness of lung adenocarcinoma via activating WNT/β-catenin signaling[J]. Proc Natl Acad Sci U S A, 2019, 116(28): 14019-14028. |